
|Articles|August 6, 2013
Targeted Therapies in Oncology
- July 2013
- Volume 2
- Issue 4
ASCO Quick Reference Chart
Author(s)Anna Azvolinsky, PhD
A quick reference chart of the key clinical trials presented at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting.
Advertisement
Articles in this issue
almost 13 years ago
NCCN Guidelines Updates: Solid Tumorsalmost 13 years ago
Targeted Advances in Melanomaalmost 13 years ago
NCCN Guidelines Updates: Hematologic Malignanciesalmost 13 years ago
Exploring the Potential for Expansion of Anti-HER2 Therapyalmost 13 years ago
The Changing Landscape of Oncology: Impact for Payers and Providersalmost 13 years ago
Positive Findings for Nab-Paclitaxel/Gemcitabine Combinationalmost 13 years ago
Changing Landscape for Genetic Testingalmost 13 years ago
Ibrutinib/R-CHOP Combination Achieves 100% Response Rate in NHLalmost 13 years ago
Ganetespib-Docetaxel Combination Improves SurvivalAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
2
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
5

































